chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, she started having joint pain in her neck about a week after the vaccine.  She had a lot of pain in her neck and headaches in the back of her head . Then she developed very strange carpal tunnel in her right arm and wrist and had to start wearing a brace, and then started in her left arm.  In the meantime she had lots of numbness and tingling and electric shock type feeling, especially in her extremities but from under arm running down her arms, and down her legs to her toes.  She developed a UTI that was resistant to antibiotics.  On 1/17/22 she woke up in the middle of the night and could not see out of her right eye.  She has seen a lot of specialists and her right optic nerve is permanently damaged.  Her retinal doctor said that he had seen a lot of people with eye problems following vaccines but hers was the worst.  She has also seen a neurologist and neurosurgeon that it was probably caused by the vaccine and not get anymore.  She has had multiple tests.  She saw an ENT who said that he felt it was neurological from the vaccine.  4-5 doctors concur that this is vaccine related.  She also has had strange rash breakouts on her left thigh.    She has been treated with Prednisone for about 3 months, was given antibiotics for the UTI (3 rounds of this).  She was tested for Lyme disease and that was negative.  She also saw a neuro-ophthalmologist who tried to reduce pressure in the eye.  he also did a lumbar puncture and multiple tests, every test known to man according to her. She is not on anything right now . Diamox 250 mg was tried and is now off of that.    She has been to local clinic, four different kinds of eye doctors, neurologist, "you name it, I've seen them".   She has had swelling in her optic nerve and that is permanent damage to the right eye.  She can seen out of it, but it is not right and strange.  Like she has gray cellophane over it and blurred and fragmented.    Her BP was also fluctuating and felt due to Prednisone.  She went to the ER with high BP.  She has had every heart scan, brain scan and all tests were negative.  She did not have any conditions prior to the vaccine.
redness at the site of injection; arm swelling; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th December 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced injection site erythema and swelling arm. On an unknown date, the outcome of the injection site erythema and swelling arm were recovered/resolved.   It was unknown if the reporter considered the injection site erythema and swelling arm to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR062396   Additional Information: GSK Receipt Date: 01-APR-2022 Reporter's Comments: The case was reported by the patient. The reporter was given information as per content and package insert and was given medical disclaimer and referred to health care professional (HCP). The reporter consented to follow up.  Consent obtained to contact consumer and health care professional for follow-up. Additional Supportive Information:  This case was linked with case US2022058855, reported by same reporter. For tolerance to the 2nd dose refer case US2022AMR062396.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022058855:Husband's case US-GLAXOSMITHKLINE-US2022AMR062396:Same patient and reporter
This spontaneous case reported by a consumer, describes the occurrence of COVID-19 (tested positive for COVID-19) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Apr 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 5, 2021, patient experienced COVID-19 (tested positive for COVID-19). At the time of the report, COVID-19 (tested positive for COVID-19) outcome: unknown. Diagnostic results: On Apr 5, 2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
Patient has not reported an adverse event. Patient was given undiluted Pfizer vaccine 0.3 mL, approximately 6 doses worth.
Patient developed Guillian Barré syndrome 3 weeks postvaccination  9/19/08  Reviewed hospital medical records of 5/2-5/6/2008. FINAL DX: Miller Fisher variant GBS; asymtomatic nonsustained v-tach; constipation. Records reveal patient seen in neurologist office on day of admit for EMG which was abnormal & sent to hospital for IVIG x 5 days.  Patient experienced paresthesia, tingling, numbness, facial weakness, extremity weakness, diffuse areflexia.  Neuro & cardio consults done.  Improved & d/c to home w/neuro, cardio & PCP f/u.  8/22/08 Reviewed hospital medical records of 4/27-4/28/2008 FINAL DX: None provided.  Admit dx: headache, transient expressive aphasia Records reveal patient experienced HA, abdominal discomfort & generalized muscle soreness x 5 days then mouth feeling abnormal, weakness of tongue, decreased sensation of skin, difficulty sleeping & difficulty forming words.  Facial weakness noted in ER.  23-hour admission for observation & Neuro consult obtained.  D/C to home on antiviral meds & steroid taper to f/u w/Neuro as outpatient. .
I started to have a slow onset of symptoms after receiving the first vaccine, but I didn't pay much attention to it. I have asthma, so I know I have problems with breathing. After receiving the 2nd dose I really noticed everything that was changing. I noticed that I started having a flip/flop feeling with my heart. If I would stand up, I would notice I would start having palpitations. I was very short of breath, but only when I move. I tried my inhaler, but it wasn't helping. I went to the urgent care on 02/16, but the sent me to the ER. At the ER, they ran some tests to see if there was a pulmonary embolism. I had blood work completed and they were checking my heart and said that everything was fine. I was given 60mg of prednisone and the very next day, my symptoms had gone away. I feel like it's been a battle and it felt like a month before I got back to where I needed to be. I did go to a cardiologist and she said that she didn't see anything wrong.
Cold sweats, migraine, body aches, brain fog, fatigue. It lasted 36-38 hours
No Adverse reaction, pt was given normal gray cap Pfizer for booster and not Bivalent. Grabbed wrong vial when drawing up vaccine
Patient is currently 17 years old but received dose 1  moderna so per CDC guidelines, Dose 2 administered as off-label use. Patient educated of off-label use.
I started to get hives a few hours after receiving the shot. The next morning, I woke up and felt really run down and my arm hurt a lot.
Day 2 after receiving the vaccine, patient developed a small lump, size of a pea, on her right lower lip. Day 3 the lump was the size of a grape, swollen and painful.  After seeing her primary care doctor (on day 3) she was diagnosed with a cold sore on her right lower lip; however, prior to the vaccine the patient has never had a cold sore before. We believe this to be a direct result of the vaccine.
Hives around the entire base of the neck, both armpits, both arms and torso. Patient given 25mg of Benadryl. Hives started to go away after 90 minutes. No other medication given. Patient went home and went to bed and was fine the next morning.
experienced issues with depth perception; nausea; vomiting; This is a spontaneous report received from contactable reporter(s) (Nurse) from a sales representative. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 Immunization. The following information was reported: ALTERED VISUAL DEPTH PERCEPTION (non-serious), outcome "unknown", described as "experienced issues with depth perception"; NAUSEA (non-serious), outcome "unknown"; VOMITING (non-serious), outcome "unknown".  Additional information: Description of Event: Female nurse received 2nd dose of Pfizer COVID vaccine 2 months after having a baby. She experienced issues with depth perception, nausea, vomiting. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pain at injection site; fever; nausea; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number TB2PK, expiry date 5th October 2021) for prophylaxis.   On 3rd October 2019, the patient received the 1st dose of Shingrix. On an unknown date, the dose was an unknown dose. On 3rd October 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, fever and nausea. On an unknown date, the outcome of the injection site pain, fever and nausea were recovered/resolved.   It was unknown if the reporter considered the injection site pain, fever and nausea to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported but it could be 59 or 60 years After vaccination with dose of Shingrix, the patient had pain at the injection site, fever, and nausea which last for approximately three days. The reporter consented to follow up. For the tolerence of 2nd dose refere case US2019AMR224793.
attendee states she felt a little light headed, skin warm and dry, VS within normal range, declined further VSigns and left without incident after education given
Pt waited the 15 min and was feeling fine.  No SOB. She left the clinic with her Nephew but after leaving felt like she was starting to get dizzy.  She returned to clinic and was pale and clammy.  We took her to procedure room and had a provider assess her.
ADVERSELY AFFECTED; This spontaneous report received from a consumer via a company representative concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced adversely affected. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adversely affected was not reported. This report was non-serious.
1st dose on 2018, 2nd on 2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 95G27, expiry date 10th September 2023) for prophylaxis.   Previously administered products included Shingrix (On 13th June 2018, received 1st dose ).   On 15th September 2022, the patient received the 2nd dose of Shingrix. On 15th September 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt date: 17-Feb-2023. Reporters Comment: Reporter enquired about the third dose. Confirmed no third dose administered. The reporter did not consent to follow-up. Additional Supportive Information: Patient received 2nd dose of Shingrix late than the recommended schedule, which led to lengthening of vaccination schedule.
Admitted 4/1/2021 and discharged to Sunrise assisted living 5/14/21. Return admission to Hospital from hospital 7/17/21 w/dx R femur fracture under Hospice Comfort Care for end of life. Expired at facility 7/18/21 at hospital.
The pt developed a severe headache and muscle spasms in her neck and thighs. 48 hours later, the pt developed bleeding gums and swollen lips saw her physician on 11/16 and was treated with a prescription antihistamine.
Patient stated she developed a headache the morning after vaccination on 3/20/18. According to the patient, this progressed to body aches and fever of 102 degrees F. Fever broke the morning of 3/21/18.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient fainted about 5 minutes after vaccination. Came to within one minute. Took blood pressure 125/76 pulse 64. Patient layed down for 5 minutes and then sat for 15.  He drank some gaterade.
I had a fever, headache, chills, swollen throat, full-body aches, and spasm, severe shortness of breath. I took ibuprofen and tylenol but it did not work. I went to the Urgent Care ER for help nearby and was given antibiotics, zpack, and inhaler and told to go to a larger facility if this did not help.
Headache, Myalgia, Fever, Nausea Vomiting, chills Narrative: Temp of 101-102F. Took Tylenol and attempted to eat and vomit what she ate, no nausea since, able to keep water down.
Hospitalized for7 days for severe sepsis secondary to COVID 19 pneumonia. Received IV Rocephin, azithromycin,oxygen, remdesivir, decadron, albuterol, encouraged to self prone. Acute ulmonary emboli on lovenox. Discharged on home health
Patient reported moderate swelling, redness, itching at injection site that started 24 hours after administration that has continued/increased 48 hours after administration. Area is also warm to touch. Pt also reported mild facial swelling above left cheek but is not sure if related to vaccine.
I was diagnosed with Mono on March 14, 2021.  I started experiencing symptoms on March 8, 2021.  I received my first dose of the vaccine on March 2, 2021.  I contracted COVID-19 around Jan. 25, 2021.  I am wondering how the combination of having the antibodies, having had COVID, getting the vaccine having the antibodies and contracting Mono may coincide.  I am also wondering if it is safe and healthy for me to get my second dose scheduled for March 30, 2021.
headache, congestion, throat pain, hoarseness, Left neck pain, left tonsil blood blister; seen by physician today; quarters x three days; medication: motrin, entex,pse tablets for congestion; seen at March by another MD who concurred
Within almost twelve hours I developed intense itching on my arm in four different places with redness and the within 16 hours large bulbous areas. I have pics if you would like them.
The patient presented to his PCP's office with a 2 day history of chest pain associated with deep inhalation NOT relieved by heat or Tylenol. He was vaccinated with the Moderna COVID vaccine on May 5th which caused fevers and sore throat that resolved. His pleuritic left sided chest pain began 11 days from vaccination. Given the symptoms, the PCP ordered a CXR and d-dimer. Because of the elevated d-dimer and tachycardia while in the office, she ordered a CT chest for PE protocol. This showed bilateral pulmonary emboli so the patient was directed to the ER. He was admitted and started on anticoagulation therapy. Given the CT chest findings of adenopathy, Hemotalogy-Oncology service was consulted and ordered labs.
Dermatographia- all over body itchiness needing Benadryl, Zyrtec D, and Atarax to control itching, and at day 5 post vaccine booster joint pain and swelling severe, Interrupting sleep and affecting use of arms.
On 9/4/99, the pt experienced a feeling of hearing loss, as though her ear was clogged.
8/22 am itchy papular rash trunk/neck. No other allergic symptoms.
A report has been received from a Physician concerning a 74 year old, Male subject, who has been receiving Nasal FLUMIST QUADRIVALENT (Intranasal). The patient's medical history included Reaction to flu shot. The patient's concurrent disease(s) included DM II, HTN, Hypothyroidism, GERD, Depression, DJD and HLD. Concomitant medications included Tramadol, Gabapentin, Hydrochlorothiazide, Acetylsalicylic acid, Levothyroxine, Lansoprazole, Ergocalciferol and Escitalopram oxalate. FLUMIST QUADRIVALENT (Intranasal) started on 18-Oct-2013. It was reported that a 74 year old patient received FLUMIST on 18-Oct-2013. The outcome of the event of 74 yo patient received FLUMIST is unknown. The report was considered to be non-serious. Summary of follow-up information received by MedImmune on 02-Dec-2013 from Physician: Concomitant disease and relevant history added. Concomitant medications added. Form completed date updated. Corrected Report 12-Dec-2013: Reporter types changed for two reporters changed. Start date of event and product added. Reporter type Responsible Physician deleted.
The following morning after receiving vaccine the patient  reported severe nausea and vomiting.  He reported extreme fatigue and body aches as well. All of these symptoms lasted for about 24 hours. He also reported signifcant injection site pain that lasted about 4 days.
I feel very bad; High blood sugar always; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I feel very bad), HYPERGLYCAEMIA (High blood sugar always) and FATIGUE (extreme fatigue) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (I feel very bad), HYPERGLYCAEMIA (High blood sugar always) and FATIGUE (extreme fatigue). At the time of the report, FEELING ABNORMAL (I feel very bad), HYPERGLYCAEMIA (High blood sugar always) and FATIGUE (extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: High blood sugar always. On an unknown date, Weight: lost a lot of weight.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact
Rash non itchy covering trunk of body, front and back. Insomnia first night. Headache, muscle pain. Neck stiffness. I have photos available of the rash if someone can contact me for them.
Incorrect storage of drug; No adverse event; This spontaneous report as received from an office manager refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 (units not reported), lot # T010311, expiration date 24-MAR-2022 (route was not reported) for prophylaxis. The temperature excursion was -9.51 C for 56 minutes due to data logger. A previous temperature excursion was not reported.       This is one of four reports received from the same source.; Sender's Comments:  US-009507513-2102USA005039: US-009507513-2102USA004947: US-009507513-2102USA004607:
Migraine; Severe constipation; nausea; Fever of about 101 degrees; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Apr2022 16:15 (Lot number: FJ9943) at the age of 68 years as dose 4 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies:Shellfish" (unspecified if ongoing), notes: Known allergies:Shellfish. Concomitant medication(s) included: ATORVASTATIN; FOLIC ACID; BIOTIN; VIT C. Past drug history included: Neomycin, reaction(s): "Allergies: topical neomycin", notes: Known allergies: topical neomycin; Formaldehyde, reaction(s): "Allergies: formaldehyde producers", notes: Known allergies: formaldehyde producers. Vaccination history included: Bnt162b2 (Dose Number: 3, Batch/Lot No: FF2588, Location of injection: Arm Left, Fever of about 101 degrees), administration date: 20Sep2021, when the patient was 67 years old, for Covid-19 Immunization, reaction(s): "Fever", "Migraine"; Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8727, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 24Mar2021, when the patient was 67 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6205, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 03Mar2021, when the patient was 67 years old, for Covid-19 Immunization. The following information was reported: MIGRAINE (non-serious) with onset 05Apr2022 06:00, outcome "recovering", described as "Migraine"; CONSTIPATION (non-serious) with onset 05Apr2022 06:00, outcome "recovering", described as "Severe constipation"; NAUSEA (non-serious) with onset 05Apr2022 06:00, outcome "recovering", described as "nausea"; PYREXIA (non-serious) with onset 05Apr2022 06:00, outcome "recovering", described as "Fever of about 101 degrees". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of migraine, constipation, nausea, pyrexia.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Also she  received medication Centrum within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.